Salivary duct carcinoma: A prospective multicenter study of 61 cases of the R éseau d'Expertise Français des Cancers ORL Rares

ConclusionSalivary duct carcinoma prognosis is poor and is correlated with tumor stage and lymph node classification. Androgen receptor and HER2/neu should be tested as they offer the possibility of targeted therapies.

Source: Head and Neck - November 13, 2018 Category: ENT & OMF Authors: Aude Villepelet, Marine Lef èvre, Benjamin Verillaud, François Janot, Renaud Garrel, Sébastien Vergez, Chloé Bertolus, Olivier Malard, Ludovic Gabory, Olivier Mauvais, Bertrand Baujat, the REFCOR members Tags: ORIGINAL ARTICLE Source Type: research